Denga (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Denga" in Polish language version.

refsWebsite

Global rank Polish rank

32nih.gov

4^th place

7^th place

31doi.org

2^nd place

6^th place

7books.google.com

3^rd place

27^th place

5cdc.gov

218^th place

561^st place

3asm.org

3,555^th place

3,305^th place

3web.archive.org

1^st place

3who.int

195^th place

256^th place

1eurosurveillance.org

low place

1neurologyindia.com

low place

1nature.com

234^th place

204^th place

1jidc.org

low place

1bbc.co.uk

8^th place

22^nd place

1thelancet.com

2,393^rd place

1,131^st place

asm.org

cmr.asm.org

Gubler DJ. Dengue and dengue hemorrhagic fever. „Clin. Microbiol. Rev.”. 11 (3), s. 480–96, 07 1998. PMID: 9665979. PMCID: PMC88892.
Henchal E.A., Putnak J.R.. The dengue viruses. „Clin. Microbiol. Rev.”. 3 (4), s. 376–96, 10 1990. DOI: 10.1128/CMR.3.4.376. PMID: 2224837. PMCID: PMC358169.
Martina BE, Koraka P, Osterhaus AD. Dengue virus pathogenesis: an integrated view. „Clin. Microbiol. Rev.”. 22 (4), s. 564–81, 10 2009. DOI: 10.1128/CMR.00035-09. PMID: 19822889. PMCID: PMC2772360.

bbc.co.uk

news.bbc.co.uk

'Bug' could combat dengue fever. [w:] BBC NEWS [on-line]. British Broadcasting Corporation, 2-01-2009.

books.google.com

Halstead SB: Dengue (Tropical Medicine: Science and Practice). River Edge, N.J.: Imperial College Press, 2008, s. 1–10. ISBN 1-84816-228-6.
Barrett AD, Stanberry LR: Vaccines for biodefense and emerging and neglected diseases. San Diego: Academic, 2009, s. 287–323. ISBN 0-12-369408-6.
Tony Solomonides: Healthgrid applications and core technologies : proceedings of HealthGrid 2010. Wyd. [Online-Ausg.]. Amsterdam: IOS Press, 2010, s. 235. ISBN 978-1-60750-582-2.
Vassil St. Georgiev ; foreword by Anthony S. Fauci: National Institute of Allergy and Infectious Diseases, NIH.. Wyd. 1. Totowa, N.J.: Humana, 2009, s. 268. ISBN 978-1-60327-297-1.
Scott Halstead: Volume 5 of Tropical medicine. Imperial College Press, 2008, s. 429. ISBN 978-1-84816-229-7.
Scott B. Halstead: Dengue. London: Imperial College Press, 2008, s. 180. ISBN 978-1-84816-228-0.
I Fong: Challenges in Infectious Diseases. Springer, 2013, s. 219. ISBN 978-1-4614-4496-1.

cdc.gov

wwwnc.cdc.gov

Anonymous. Etymologia: dengue. „Emerg. Infec. Dis.”. 12 (6), s. 893, 2006. DOI: 10.3201/eid1206.ET1206.
Travelers' Health Outbreak Notice, Centers for Disease Control and Prevention, 2 czerwca 2010 [dostęp 2010-08-27] [zarchiwizowane z adresu 2010-08-26] .
Center for Disease Control and Prevention: Chapter 5 – dengue fever (DF) and dengue hemorrhagic fever (DHF). [w:] 2010 Yellow Book [on-line]. [dostęp 2010-12-23].

cdc.gov

Wilder-Smith A, Chen LH, Massad E, Wilson ME. Threat of dengue to blood safety in dengue-endemic countries. „Emerg. Infect. Dis.”. 15 (1), s. 8–11, 01 2009. DOI: 10.3201/eid1501.071097. PMID: 19116042. PMCID: PMC2660677.
New CDC test for dengue approved, Centers for Disease Control and Prevention, 20 czerwca 2012 .

doi.org

Anonymous. Etymologia: dengue. „Emerg. Infec. Dis.”. 12 (6), s. 893, 2006. DOI: 10.3201/eid1206.ET1206.
Simmons CP, Farrar JJ, Nguyen vV, Wills B. Dengue. „N Engl J Med”. 366 (15), s. 1423–32, 04 2012. DOI: 10.1056/NEJMra1110265. PMID: 22494122.
Henchal E.A., Putnak J.R.. The dengue viruses. „Clin. Microbiol. Rev.”. 3 (4), s. 376–96, 10 1990. DOI: 10.1128/CMR.3.4.376. PMID: 2224837. PMCID: PMC358169.
Gould EA, Solomon T. Pathogenic flaviviruses. „The Lancet”. 371 (9611), s. 500–9, 02 2008. DOI: 10.1016/S0140-6736(08)60238-X. PMID: 18262042.
Whitehorn J, Farrar J. Dengue. „Br. Med. Bull.”. 95, s. 161–73, 2010. DOI: 10.1093/bmb/ldq019. PMID: 20616106.
Ranjit S, Kissoon N. Dengue hemorrhagic fever and shock syndromes. „Pediatr. Crit. Care Med.”. 12 (1), s. 90–100, 01 2011. DOI: 10.1097/PCC.0b013e3181e911a7. PMID: 20639791.
Varatharaj A.. Encephalitis in the clinical spectrum of dengue infection. „Neurol. India”. 58 (4), s. 585–91, 2010. DOI: 10.4103/0028-3886.68655. PMID: 20739797.
Chen LH, Wilson ME. Dengue and chikungunya infections in travelers. „Curr. Opin. Infect. Dis.”. 23 (5), s. 438–44, 10 2010. DOI: 10.1097/QCO.0b013e32833c1d16. PMID: 20581669.
Rodenhuis-Zybert IA, Wilschut J, Smit JM. Dengue virus life cycle: viral and host factors modulating infectivity. „Cell. Mol. Life Sci.”. 67 (16), s. 2773–86, 08 2010. DOI: 10.1007/s00018-010-0357-z. PMID: 20372965.
Guzman MG, Halstead SB, Artsob H, et al.. Dengue: a continuing global threat. „Nat. Rev. Microbiol.”. 8 (12 Suppl), s. S7–S16, 12 2010. DOI: 10.1038/nrmicro2460. PMID: 21079655.
Normile D. Surprising new dengue virus throws a spanner in disease control efforts. „Science”. 342 (6157), s. 415, 2013. DOI: 10.1126/science.342.6157.415. PMID: 24159024. (ang.).
Kristina B. Clark, Nattawat Onlamoon Hui-Mien Hsiao Guey C. Perng & Francois Villinger. Can non-human primates serve as models for investigating dengue disease pathogenesis?. „Frontiers in Microbiology”. 4, s. 305, 2013. DOI: 10.3389/fmicb.2013.00305. PMCID: PMC3795305. (ang.).
Wilder-Smith A, Chen LH, Massad E, Wilson ME. Threat of dengue to blood safety in dengue-endemic countries. „Emerg. Infect. Dis.”. 15 (1), s. 8–11, 01 2009. DOI: 10.3201/eid1501.071097. PMID: 19116042. PMCID: PMC2660677.
Stramer SL, Hollinger FB, Katz LM, et al.. Emerging infectious disease agents and their potential threat to transfusion safety. „Transfusion”. 49 Suppl 2, s. 1S–29S, 8 2009. DOI: 10.1111/j.1537-2995.2009.02279.x. PMID: 19686562.
Teo D, Ng LC, Lam S. Is dengue a threat to the blood supply?. „Transfus Med”. 19 (2), s. 66–77, 04 2009. DOI: 10.1111/j.1365-3148.2009.00916.x. PMID: 19392949. PMCID: PMC2713854.
Martina BE, Koraka P, Osterhaus AD. Dengue virus pathogenesis: an integrated view. „Clin. Microbiol. Rev.”. 22 (4), s. 564–81, 10 2009. DOI: 10.1128/CMR.00035-09. PMID: 19822889. PMCID: PMC2772360.
S. Rajapakse, C. Rodrigo, S. Maduranga, AC. Rajapakse. Corticosteroids in the treatment of dengue shock syndrome.. „Infect Drug Resist”. 7, s. 137-43, 2014. DOI: 10.2147/IDR.S55380. PMID: 24899817.
A. Sridharan, Q. Chen, KF. Tang, EE. Ooi i inni. Inhibition of megakaryocyte development in the bone marrow underlies dengue virus-induced thrombocytopenia in humanized mice.. „J Virol”. 87 (21), s. 11648-58, Nov 2013. DOI: 10.1128/JVI.01156-13. PMID: 23966397.
M. Saito, K. Oishi, S. Inoue, EM. Dimaano i inni. Association of increased platelet-associated immunoglobulins with thrombocytopenia and the severity of disease in secondary dengue virus infections.. „Clin Exp Immunol”. 138 (2), s. 299-303, Nov 2004. DOI: 10.1111/j.1365-2249.2004.02626.x. PMID: 15498040.
S. Wang, R. He, J. Patarapotikul, BL. Innis i inni. Antibody-enhanced binding of dengue-2 virus to human platelets.. „Virology”. 213 (1), s. 254-7, Oct 1995. DOI: 10.1006/viro.1995.1567. PMID: 7483271.
DS. Sun, CC. King, HS. Huang, YL. Shih i inni. Antiplatelet autoantibodies elicited by dengue virus non-structural protein 1 cause thrombocytopenia and mortality in mice.. „J Thromb Haemost”. 5 (11), s. 2291-9, Nov 2007. DOI: 10.1111/j.1538-7836.2007.02754.x. PMID: 17958746.
CP Simmons, Farrar, JJ; Nguyen, vV; Wills, B. Dengue. „The New England Journal of Medicine”. 366 (15), s. 1423–32, 2012-04-12. DOI: 10.1056/NEJMra1110265. PMID: 22494122.
V Wiwanitkit. Dengue fever: diagnosis and treatment. „Expert review of anti-infective therapy”. 8 (7), s. 841–5, 2010 Jul. DOI: 10.1586/eri.10.53. PMID: 20586568.
Bhatt S, Gething PW, Brady OJ, et al.. The global distribution and burden of dengue. „Nature”. 496 (7446), s. 504–7, 04 2013. DOI: 10.1038/nature12060. PMID: 23563266. PMCID: PMC3651993.
Duane J Gubler, Shepard DS, Undurraga EA, Halasa YA. Economic and disease burden of dengue in Southeast Asia. „PLoS Negl Trop Dis”. 7 (2), s. e2055, 2013. DOI: 10.1371/journal.pntd.0002055. PMID: 23437406. PMCID: PMC3578748.
Webster DP, Farrar J, Rowland-Jones S. Progress towards a dengue vaccine. „Lancet Infect Dis”. 9 (11), s. 678–87, 11 2009. DOI: 10.1016/S1473-3099(09)70254-3. PMID: 19850226.
Maria Rosario Capeding, Huu Tran, Rezeki S Hadinegoro. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. „The Lancet”, Early Online Publication, 11 July 2014. DOI: 10.1016/S0140-6736(14)61060-6. (ang.).
Guy B, Barrere B, Malinowski C, Saville M, Teyssou R, Lang J. From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine. „Vaccine”. 29 (42), s. 7229–41, 9 2011. DOI: 10.1016/j.vaccine.2011.06.094. PMID: 21745521.
Sampath A, Padmanabhan R. Molecular targets for flavivirus drug discovery. „Antiviral Res.”. 81 (1), s. 6–15, 01 2009. DOI: 10.1016/j.antiviral.2008.08.004. PMID: 18796313. PMCID: PMC2647018.
Noble CG, Chen YL, Dong H, et al.. Strategies for development of Dengue virus inhibitors. „Antiviral Res.”. 85 (3), s. 450–62, 03 2010. DOI: 10.1016/j.antiviral.2009.12.011. PMID: 20060421.
Tomlinson SM, Malmstrom RD, Watowich SJ. New approaches to structure-based discovery of dengue protease inhibitors. „Infectious Disorders Drug Targets”. 9 (3), s. 327–43, 06 2009. DOI: 10.2174/1871526510909030327. PMID: 19519486.

eurosurveillance.org

Reiter P. Yellow fever and dengue: a threat to Europe?. „Euro Surveill”. 15 (10), s. 19509, 2010-03-11. PMID: 20403310.

jidc.org

Wiwanitkit V. Unusual mode of transmission of dengue. „Journal of Infection in Developing Countries”. 4 (1), s. 51–4, 01 2010. PMID: 20130380.

nature.com

Guzman MG, Halstead SB, Artsob H, et al.. Dengue: a continuing global threat. „Nat. Rev. Microbiol.”. 8 (12 Suppl), s. S7–S16, 12 2010. DOI: 10.1038/nrmicro2460. PMID: 21079655.

neurologyindia.com

Varatharaj A.. Encephalitis in the clinical spectrum of dengue infection. „Neurol. India”. 58 (4), s. 585–91, 2010. DOI: 10.4103/0028-3886.68655. PMID: 20739797.

nih.gov

ncbi.nlm.nih.gov

Gubler DJ. Dengue and dengue hemorrhagic fever. „Clin. Microbiol. Rev.”. 11 (3), s. 480–96, 07 1998. PMID: 9665979. PMCID: PMC88892.
Simmons CP, Farrar JJ, Nguyen vV, Wills B. Dengue. „N Engl J Med”. 366 (15), s. 1423–32, 04 2012. DOI: 10.1056/NEJMra1110265. PMID: 22494122.
Henchal E.A., Putnak J.R.. The dengue viruses. „Clin. Microbiol. Rev.”. 3 (4), s. 376–96, 10 1990. DOI: 10.1128/CMR.3.4.376. PMID: 2224837. PMCID: PMC358169.
Gould EA, Solomon T. Pathogenic flaviviruses. „The Lancet”. 371 (9611), s. 500–9, 02 2008. DOI: 10.1016/S0140-6736(08)60238-X. PMID: 18262042.
Whitehorn J, Farrar J. Dengue. „Br. Med. Bull.”. 95, s. 161–73, 2010. DOI: 10.1093/bmb/ldq019. PMID: 20616106.
Reiter P. Yellow fever and dengue: a threat to Europe?. „Euro Surveill”. 15 (10), s. 19509, 2010-03-11. PMID: 20403310.
Ranjit S, Kissoon N. Dengue hemorrhagic fever and shock syndromes. „Pediatr. Crit. Care Med.”. 12 (1), s. 90–100, 01 2011. DOI: 10.1097/PCC.0b013e3181e911a7. PMID: 20639791.
Varatharaj A.. Encephalitis in the clinical spectrum of dengue infection. „Neurol. India”. 58 (4), s. 585–91, 2010. DOI: 10.4103/0028-3886.68655. PMID: 20739797.
Chen LH, Wilson ME. Dengue and chikungunya infections in travelers. „Curr. Opin. Infect. Dis.”. 23 (5), s. 438–44, 10 2010. DOI: 10.1097/QCO.0b013e32833c1d16. PMID: 20581669.
Rodenhuis-Zybert IA, Wilschut J, Smit JM. Dengue virus life cycle: viral and host factors modulating infectivity. „Cell. Mol. Life Sci.”. 67 (16), s. 2773–86, 08 2010. DOI: 10.1007/s00018-010-0357-z. PMID: 20372965.
Guzman MG, Halstead SB, Artsob H, et al.. Dengue: a continuing global threat. „Nat. Rev. Microbiol.”. 8 (12 Suppl), s. S7–S16, 12 2010. DOI: 10.1038/nrmicro2460. PMID: 21079655.
Normile D. Surprising new dengue virus throws a spanner in disease control efforts. „Science”. 342 (6157), s. 415, 2013. DOI: 10.1126/science.342.6157.415. PMID: 24159024. (ang.).
Kristina B. Clark, Nattawat Onlamoon Hui-Mien Hsiao Guey C. Perng & Francois Villinger. Can non-human primates serve as models for investigating dengue disease pathogenesis?. „Frontiers in Microbiology”. 4, s. 305, 2013. DOI: 10.3389/fmicb.2013.00305. PMCID: PMC3795305. (ang.).
Wilder-Smith A, Chen LH, Massad E, Wilson ME. Threat of dengue to blood safety in dengue-endemic countries. „Emerg. Infect. Dis.”. 15 (1), s. 8–11, 01 2009. DOI: 10.3201/eid1501.071097. PMID: 19116042. PMCID: PMC2660677.
Stramer SL, Hollinger FB, Katz LM, et al.. Emerging infectious disease agents and their potential threat to transfusion safety. „Transfusion”. 49 Suppl 2, s. 1S–29S, 8 2009. DOI: 10.1111/j.1537-2995.2009.02279.x. PMID: 19686562.
Teo D, Ng LC, Lam S. Is dengue a threat to the blood supply?. „Transfus Med”. 19 (2), s. 66–77, 04 2009. DOI: 10.1111/j.1365-3148.2009.00916.x. PMID: 19392949. PMCID: PMC2713854.
Wiwanitkit V. Unusual mode of transmission of dengue. „Journal of Infection in Developing Countries”. 4 (1), s. 51–4, 01 2010. PMID: 20130380.
Martina BE, Koraka P, Osterhaus AD. Dengue virus pathogenesis: an integrated view. „Clin. Microbiol. Rev.”. 22 (4), s. 564–81, 10 2009. DOI: 10.1128/CMR.00035-09. PMID: 19822889. PMCID: PMC2772360.
S. Rajapakse, C. Rodrigo, S. Maduranga, AC. Rajapakse. Corticosteroids in the treatment of dengue shock syndrome.. „Infect Drug Resist”. 7, s. 137-43, 2014. DOI: 10.2147/IDR.S55380. PMID: 24899817.
A. Sridharan, Q. Chen, KF. Tang, EE. Ooi i inni. Inhibition of megakaryocyte development in the bone marrow underlies dengue virus-induced thrombocytopenia in humanized mice.. „J Virol”. 87 (21), s. 11648-58, Nov 2013. DOI: 10.1128/JVI.01156-13. PMID: 23966397.
M. Saito, K. Oishi, S. Inoue, EM. Dimaano i inni. Association of increased platelet-associated immunoglobulins with thrombocytopenia and the severity of disease in secondary dengue virus infections.. „Clin Exp Immunol”. 138 (2), s. 299-303, Nov 2004. DOI: 10.1111/j.1365-2249.2004.02626.x. PMID: 15498040.
S. Wang, R. He, J. Patarapotikul, BL. Innis i inni. Antibody-enhanced binding of dengue-2 virus to human platelets.. „Virology”. 213 (1), s. 254-7, Oct 1995. DOI: 10.1006/viro.1995.1567. PMID: 7483271.
DS. Sun, CC. King, HS. Huang, YL. Shih i inni. Antiplatelet autoantibodies elicited by dengue virus non-structural protein 1 cause thrombocytopenia and mortality in mice.. „J Thromb Haemost”. 5 (11), s. 2291-9, Nov 2007. DOI: 10.1111/j.1538-7836.2007.02754.x. PMID: 17958746.
CP Simmons, Farrar, JJ; Nguyen, vV; Wills, B. Dengue. „The New England Journal of Medicine”. 366 (15), s. 1423–32, 2012-04-12. DOI: 10.1056/NEJMra1110265. PMID: 22494122.
V Wiwanitkit. Dengue fever: diagnosis and treatment. „Expert review of anti-infective therapy”. 8 (7), s. 841–5, 2010 Jul. DOI: 10.1586/eri.10.53. PMID: 20586568.
Bhatt S, Gething PW, Brady OJ, et al.. The global distribution and burden of dengue. „Nature”. 496 (7446), s. 504–7, 04 2013. DOI: 10.1038/nature12060. PMID: 23563266. PMCID: PMC3651993.
Duane J Gubler, Shepard DS, Undurraga EA, Halasa YA. Economic and disease burden of dengue in Southeast Asia. „PLoS Negl Trop Dis”. 7 (2), s. e2055, 2013. DOI: 10.1371/journal.pntd.0002055. PMID: 23437406. PMCID: PMC3578748.
Webster DP, Farrar J, Rowland-Jones S. Progress towards a dengue vaccine. „Lancet Infect Dis”. 9 (11), s. 678–87, 11 2009. DOI: 10.1016/S1473-3099(09)70254-3. PMID: 19850226.
Guy B, Barrere B, Malinowski C, Saville M, Teyssou R, Lang J. From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine. „Vaccine”. 29 (42), s. 7229–41, 9 2011. DOI: 10.1016/j.vaccine.2011.06.094. PMID: 21745521.
Sampath A, Padmanabhan R. Molecular targets for flavivirus drug discovery. „Antiviral Res.”. 81 (1), s. 6–15, 01 2009. DOI: 10.1016/j.antiviral.2008.08.004. PMID: 18796313. PMCID: PMC2647018.
Noble CG, Chen YL, Dong H, et al.. Strategies for development of Dengue virus inhibitors. „Antiviral Res.”. 85 (3), s. 450–62, 03 2010. DOI: 10.1016/j.antiviral.2009.12.011. PMID: 20060421.
Tomlinson SM, Malmstrom RD, Watowich SJ. New approaches to structure-based discovery of dengue protease inhibitors. „Infectious Disorders Drug Targets”. 9 (3), s. 327–43, 06 2009. DOI: 10.2174/1871526510909030327. PMID: 19519486.

thelancet.com

Maria Rosario Capeding, Huu Tran, Rezeki S Hadinegoro. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. „The Lancet”, Early Online Publication, 11 July 2014. DOI: 10.1016/S0140-6736(14)61060-6. (ang.).

web.archive.org

Anonymous: Definition of Dandy fever. MedicineNet.com, 1998-06-15. [dostęp 2010-12-25].
Travelers' Health Outbreak Notice, Centers for Disease Control and Prevention, 2 czerwca 2010 [dostęp 2010-08-27] [zarchiwizowane z adresu 2010-08-26] .
Comprehensive guidelines for prevention and control of dengue and dengue haemorrhagic fever.. Nowe Delhi, India: World Health Organization Regional Office for South-East Asia, 2011, s. 17. ISBN 978-92-9022-387-0.

who.int

Chapter 2: clinical diagnosis. W: WHO: Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. Wyd. 2. Geneva: World Health Organization, 1997, s. 12–23. ISBN 92-4-154500-3.
Neglected TropicalN.T. Diseases Neglected TropicalN.T., The 17 neglected tropical diseases, World Health Organization [dostęp 2013-04-10] .

apps.who.int

Global Strategy For Dengue Prevention And Control. World Health Organization, 2012, s. 16–17. ISBN 978-92-4-150403-4.